Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation
Individual Genetic Factors Influencing Discontinuation Risk Genetic variants in GIPR and FTO, and MC4R genes influence how individuals respond to GLP-1 medications and how quickly they regain weight after stopping
Virtually any variant of a melanocytic lesion that occurs in nongenital sites may also occur on the vulva
That 2.7 percentage point gap suggests prior receptor exposure may genuinely reduce subsequent responsiveness
It is intended for controlled laboratory work in which the investigator has already defined the identity criteria, analytical method, handling controls, and lawful research purpose
Current Evidence: GLP-1 Effects on Rheumatoid Arthritis Symptoms As of 2025, there is limited direct clinical evidence examining the effects of GLP-1 receptor agonists specifically on rheumatoid arthritis symptoms or disease progression